| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-72009 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73518 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-72654 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-72956 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-72205 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-72205 | |||
![Western Blot: CDCA7L Antibody (OTI3B5) [NBP2-46198] - Detection of CDCA7L by western blot. Samples: Whole cell lysate from prostate cancer; 40 ug. Antibodies:CDCA7L Antibody [NBP2-46198] at dilutions 1:500, 1:1000, 1:2000. Detection: Chemiluminescence with exposure of 5 seconds. Image from verified customer review.](http://images.novusbio.com/fullsize/CDCA7L-Antibody-OTI3B5-Western-Blot-NBP2-46198-img0010.jpg "Western Blot: CDCA7L Antibody (OTI3B5) [NBP2-46198] - Detection of CDCA7L by western blot. Samples: Whole cell lysate from prostate cancer; 40 ug. Antibodies:CDCA7L Antibody [NBP2-46198] at dilutions 1:500, 1:1000, 1:2000. Detection: Chemiluminescence with exposure of 5 seconds. Image from verified customer review.")
![Immunohistochemistry: CDCA7L Antibody (3B5) [NBP2-46198] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CDCA7L-Antibody-3B5-Immunohistochemistry-NBP2-46198-img0007.jpg)
![Western Blot: CDCA7L Antibody (3B5) [NBP2-46198] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CDCA7L.](http://images.novusbio.com/fullsize/CDCA7L-Antibody-3B5-Western-Blot-NBP2-46198-img0008.jpg)
![Immunohistochemistry: CDCA7L Antibody (3B5) [NBP2-46198] - Analysis of Adenocarcinoma of Human breast tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CDCA7L-Antibody-3B5-Immunohistochemistry-NBP2-46198-img0001.jpg)
![Immunohistochemistry: CDCA7L Antibody (3B5) [NBP2-46198] - Analysis of Human colon tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CDCA7L-Antibody-3B5-Immunohistochemistry-NBP2-46198-img0002.jpg)
![Immunohistochemistry: CDCA7L Antibody (3B5) [NBP2-46198] - Analysis of Carcinoma of Human kidney tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CDCA7L-Antibody-3B5-Immunohistochemistry-NBP2-46198-img0003.jpg)
![Immunohistochemistry: CDCA7L Antibody (3B5) [NBP2-46198] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CDCA7L-Antibody-3B5-Immunohistochemistry-NBP2-46198-img0004.jpg)
![Immunohistochemistry: CDCA7L Antibody (3B5) [NBP2-46198] - Analysis of Human pancreas tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CDCA7L-Antibody-3B5-Immunohistochemistry-NBP2-46198-img0005.jpg)
![Immunohistochemistry: CDCA7L Antibody (3B5) [NBP2-46198] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CDCA7L-Antibody-3B5-Immunohistochemistry-NBP2-46198-img0006.jpg)
![Western Blot: POLR2E Antibody (OTI3B5) [NBP2-00482] - POLR2A is destabilized by inhibition of oncogenic BRAFV600E signaling. Representative immunoblot of A375-P cells treated with PLX4720 or DMSO control for 16 hours, followed by cycoheximide treatment for the indicated timepoints. The lower panel shows the quantification of three independent biological replicates, normalized to the respective 0 CHX timepoint and alpha-Tubulin loading control (mean +/- SD). Image collected and cropped by CiteAb from the following publication (//www.nature.com/articles/s41598-019-44112-7), licensed under a CC-BY license.](http://images.novusbio.com/fullsize/POLR2E-Antibody-OTI3B5-Western-Blot-NBP2-00482-img0013.jpg "<b>Biological Strategies Validation. </b>Western Blot: POLR2E Antibody (OTI3B5) [NBP2-00482] - POLR2A is destabilized by inhibition of oncogenic BRAFV600E signaling. Representative immunoblot of A375-P cells treated with PLX4720 or DMSO control for 16 hours, followed by cycoheximide treatment for the indicated timepoints. The lower panel shows the quantification of three independent biological replicates, normalized to the respective 0 CHX timepoint and alpha-Tubulin loading control (mean +/- SD). Image collected and cropped by CiteAb from the following publication (//www.nature.com/articles/s41598-019-44112-7), licensed under a CC-BY license.")
![<b>Biological Strategies Validation. </b>Immunohistochemistry-Paraffin: POLR2E Antibody (OTI3B5) [NBP2-00482] - Human tonsil.](http://images.novusbio.com/fullsize/POLR2E-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP2-00482-img0012.jpg)
![Flow Cytometry: POLR2E Antibody (OTI3B5) [NBP2-00482] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-POLR2E antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/POLR2E-Antibody-OTI3B5-Flow-Cytometry-NBP2-00482-img0002.jpg)
![Western Blot: POLR2E Antibody (OTI3B5) [NBP2-00482] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY POLR2E (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-POLR2E.](http://images.novusbio.com/fullsize/POLR2E-Antibody-OTI3B5-Western-Blot-NBP2-00482-img0003.jpg)
![Western Blot: POLR2E Antibody (OTI3B5) [NBP2-00482] - Analysis of extracts (35ug) from 9 different cell lines by using anti-POLR2E monoclonal antibody.](http://images.novusbio.com/fullsize/POLR2E-Antibody-OTI3B5-Western-Blot-NBP2-00482-img0011.jpg)
![Immunohistochemistry-Paraffin: POLR2E Antibody (OTI3B5) [NBP2-00482] - Staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-POLR2E mouse monoclonal antibody.](http://images.novusbio.com/fullsize/POLR2E-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP2-00482-img0004.jpg)
![Immunohistochemistry-Paraffin: POLR2E Antibody (OTI3B5) [NBP2-00482] - Staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-POLR2E mouse monoclonal antibody.](http://images.novusbio.com/fullsize/POLR2E-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP2-00482-img0005.jpg)
![Immunohistochemistry-Paraffin: POLR2E Antibody (OTI3B5) [NBP2-00482] - Staining of paraffin-embedded Carcinoma of Human lung tissue using anti-POLR2E mouse monoclonal antibody.](http://images.novusbio.com/fullsize/POLR2E-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP2-00482-img0006.jpg)
![Immunohistochemistry-Paraffin: POLR2E Antibody (OTI3B5) [NBP2-00482] - Staining of paraffin-embedded Carcinoma of Human prostate tissue using anti-POLR2E mouse monoclonal antibody.](http://images.novusbio.com/fullsize/POLR2E-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP2-00482-img0007.jpg)
![Immunohistochemistry-Paraffin: POLR2E Antibody (OTI3B5) [NBP2-00482] - Staining of paraffin-embedded Human breast tissue using anti-POLR2E mouse monoclonal antibody.](http://images.novusbio.com/fullsize/POLR2E-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP2-00482-img0008.jpg)
![Immunohistochemistry-Paraffin: POLR2E Antibody (OTI3B5) [NBP2-00482] - Staining of paraffin-embedded Human lymphoma tissue using anti-POLR2E mouse monoclonal antibody.](http://images.novusbio.com/fullsize/POLR2E-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP2-00482-img0009.jpg)
![Immunohistochemistry-Paraffin: POLR2E Antibody (OTI3B5) [NBP2-00482] - Staining of paraffin-embedded Human pancreas tissue using anti-POLR2E mouse monoclonal antibody.](http://images.novusbio.com/fullsize/POLR2E-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP2-00482-img0010.jpg)
![Flow Cytometry: POLR2E Antibody (OTI3B5) [NBP2-00482] - Analysis of Jurkat cells, using anti-POLR2E antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/POLR2E-Antibody-OTI3B5-Flow-Cytometry-NBP2-00482-img0001.jpg)
![Western Blot: METT10D Antibody (OTI3B5) [NBP2-02026] - Analysis of extracts (35ug) from 9 different cell lines by usin g anti-METT10D monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).](http://images.novusbio.com/fullsize/METT10D-Antibody-OTI3B5-Western-Blot-NBP2-02026-img0010.jpg "Western Blot: METT10D Antibody (OTI3B5) [NBP2-02026] - Analysis of extracts (35ug) from 9 different cell lines by usin g anti-METT10D monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).")
![Immunocytochemistry/Immunofluorescence: METT10D Antibody (OTI3B5) [NBP2-02026] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY METT10D.](http://images.novusbio.com/fullsize/METT10D-Antibody-OTI3B5-Immunocytochemistry-Immunofluorescence-NBP2-02026-img0009.jpg)
![Immunohistochemistry-Paraffin: METT10D Antibody (OTI3B5) [NBP2-02026] - Staining of paraffin-embedded Human prostate tissue using anti-METT10D mouse monoclonal antibody.](http://images.novusbio.com/fullsize/METT10D-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP2-02026-img0008.jpg)
![Western Blot: METT10D Antibody (OTI3B5) [NBP2-02026] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY METT10D (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-METT10D.](http://images.novusbio.com/fullsize/METT10D-Antibody-OTI3B5-Western-Blot-NBP2-02026-img0001.jpg)
![Immunohistochemistry-Paraffin: METT10D Antibody (OTI3B5) [NBP2-02026] - Staining of paraffin-embedded Adenocarcinoma of Human colon tissue using anti-METT10D mouse monoclonal antibody.](http://images.novusbio.com/fullsize/METT10D-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP2-02026-img0002.jpg)
![Immunohistochemistry-Paraffin: METT10D Antibody (OTI3B5) [NBP2-02026] - Staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-METT10D mouse monoclonal antibody.](http://images.novusbio.com/fullsize/METT10D-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP2-02026-img0003.jpg)
![Immunohistochemistry-Paraffin: METT10D Antibody (OTI3B5) [NBP2-02026] - Staining of paraffin-embedded Carcinoma of Human bladder tissue using anti-METT10D mouse monoclonal antibody.](http://images.novusbio.com/fullsize/METT10D-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP2-02026-img0004.jpg)
![Immunohistochemistry-Paraffin: METT10D Antibody (OTI3B5) [NBP2-02026] - Staining of paraffin-embedded Carcinoma of Human prostate tissue using anti-METT10D mouse monoclonal antibody.](http://images.novusbio.com/fullsize/METT10D-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP2-02026-img0005.jpg)
![Immunohistochemistry-Paraffin: METT10D Antibody (OTI3B5) [NBP2-02026] - Staining of paraffin-embedded Carcinoma of Human thyroid tissue using anti-METT10D mouse monoclonal antibody.](http://images.novusbio.com/fullsize/METT10D-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP2-02026-img0006.jpg)
![Immunohistochemistry-Paraffin: METT10D Antibody (OTI3B5) [NBP2-02026] - Staining of paraffin-embedded Human pancreas tissue using anti-METT10D mouse monoclonal antibody.](http://images.novusbio.com/fullsize/METT10D-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP2-02026-img0007.jpg)
![Western Blot: CDCA7L Antibody (OTI3B5) - Azide and BSA Free [NBP2-72009] - Detection of CDCA7L by western blot. Samples: Whole cell lysate from prostate cancer; 40 ug. Antibodies:CDCA7L Antibody [NBP2-46198] at dilutions 1:500, 1:1000, 1:2000. Detection: Chemiluminescence with exposure of 5 seconds. Image from verified customer](http://images.novusbio.com/fullsize/CDCA7L-Antibody-OTI3B5-Azide-and-BSA-Free-Western-Blot-NBP2-72009-img0002.jpg "Western Blot: CDCA7L Antibody (OTI3B5) - Azide and BSA Free [NBP2-72009] - Detection of CDCA7L by western blot. Samples: Whole cell lysate from prostate cancer; 40 ug. Antibodies:CDCA7L Antibody [NBP2-46198] at dilutions 1:500, 1:1000, 1:2000. Detection: Chemiluminescence with exposure of 5 seconds. Image from verified customer")
![Immunohistochemistry: CDCA7L Antibody (OTI3B5) - Azide and BSA Free [NBP2-72009] - Analysis of Human pancreas tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CDCA7L-Antibody-OTI3B5-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72009-img0008.jpg)
![Western Blot: CDCA7L Antibody (OTI3B5) - Azide and BSA Free [NBP2-72009] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CDCA7L.](http://images.novusbio.com/fullsize/CDCA7L-Antibody-OTI3B5-Azide-and-BSA-Free-Western-Blot-NBP2-72009-img0001.jpg)
![Immunohistochemistry: CDCA7L Antibody (OTI3B5) - Azide and BSA Free [NBP2-72009] - Analysis of Adenocarcinoma of Human breast tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CDCA7L-Antibody-OTI3B5-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72009-img0003.jpg)
![Immunohistochemistry: CDCA7L Antibody (OTI3B5) - Azide and BSA Free [NBP2-72009] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CDCA7L-Antibody-OTI3B5-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72009-img0004.jpg)
![Immunohistochemistry: CDCA7L Antibody (OTI3B5) - Azide and BSA Free [NBP2-72009] - Analysis of Carcinoma of Human kidney tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CDCA7L-Antibody-OTI3B5-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72009-img0005.jpg)
![Immunohistochemistry: CDCA7L Antibody (OTI3B5) - Azide and BSA Free [NBP2-72009] - Analysis of Human colon tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CDCA7L-Antibody-OTI3B5-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72009-img0006.jpg)
![Immunohistochemistry: CDCA7L Antibody (OTI3B5) - Azide and BSA Free [NBP2-72009] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CDCA7L-Antibody-OTI3B5-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72009-img0007.jpg)
![Immunohistochemistry: CDCA7L Antibody (OTI3B5) - Azide and BSA Free [NBP2-72009] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CDCA7L-Antibody-OTI3B5-Azide-and-BSA-Free-Immunohistochemistry-NBP2-72009-img0009.jpg)
![Western Blot: Neurogenin-3 Antibody (OTI3B5) [NBP1-47878] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Neurogenin-3 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Neurogenin-3.](http://images.novusbio.com/fullsize/Neurogenin-3-Antibody-OTI3B5-Western-Blot-NBP1-47878-img0007.jpg "Western Blot: Neurogenin-3 Antibody (OTI3B5) [NBP1-47878] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Neurogenin-3 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Neurogenin-3.")
![Immunocytochemistry/Immunofluorescence: Neurogenin-3 Antibody (OTI3B5) [NBP1-47878] - Neurogenin3 Immunofluorescent staining of HeLa cells transiently transfected by pCMV6-ENTRY Neurogenin-3.](http://images.novusbio.com/fullsize/Neurogenin-3-Antibody-OTI3B5-Immunocytochemistry-Immunofluorescence-NBP1-47878-img0005.jpg)
![Immunohistochemistry-Paraffin: Neurogenin-3 Antibody (OTI3B5) [NBP1-47878] - Staining of paraffin-embedded Human liver tissue within the normal limits using anti-NEUROG3 mouse monoclonal antibody at 1:150 dilution.](http://images.novusbio.com/fullsize/Neurogenin-3-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP1-47878-img0008.jpg)
![Immunohistochemistry-Paraffin: Neurogenin-3 Antibody (OTI3B5) [NBP1-47878] - Staining of paraffin-embedded Human lymph node tissue using anti-Neurogenin-3 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Neurogenin-3-Antibody-OTI3B5-Immunohistochemistry-Paraffin-NBP1-47878-img0006.jpg)
![Immunoprecipitation: Neurogenin-3 Antibody (OTI3B5) [NBP1-47878] - (Negative control: IP without adding anti-NEUROG3 antibody). For each experiment, 500ul of DDK tagged NEUROG3 overexpression lysates (at 1:5 dilution with HEK293T lysate), 2ug of anti-NEUROG3 antibody and 20ul (0.1mg) of goat anti-mouse conjugated magnetic beads were mixed and incubated overnight. After extensive wash to remove any non-specific binding, the immuno-precipitated products were analyzed with rabbit anti-DDK polyclonal antibody.](http://images.novusbio.com/fullsize/Neurogenin-3-Antibody-OTI3B5-Immunoprecipitation-NBP1-47878-img0009.jpg)
![Western Blot: CYBC1 Antibody (OTI3B5) [NBP2-46594] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf62.](http://images.novusbio.com/fullsize/CYBC1-Antibody-OTI3B5-Western-Blot-NBP2-46594-img0002.jpg "Western Blot: CYBC1 Antibody (OTI3B5) [NBP2-46594] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf62.")
![Immunofluorescence: CYBC1 Antibody (OTI3B5) [NBP2-46594] - Analysis of HeLa cells.](http://images.novusbio.com/fullsize/CYBC1-Antibody-OTI3B5-Immunofluorescence-NBP2-46594-img0001.jpg)
![Western Blot: CYBC1 Antibody (OTI3B5) - Azide and BSA Free [NBP2-72205] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf62.](http://images.novusbio.com/fullsize/CYBC1-Antibody-OTI3B5-Azide-and-BSA-Free-Western-Blot-NBP2-72205-img0001.jpg "Western Blot: CYBC1 Antibody (OTI3B5) - Azide and BSA Free [NBP2-72205] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY C17orf62.")
![Immunocytochemistry/Immunofluorescence: CYBC1 Antibody (OTI3B5) - Azide and BSA Free [NBP2-72205] - Analysis of HeLa cells.](http://images.novusbio.com/fullsize/CYBC1-Antibody-OTI3B5-Azide-and-BSA-Free-Immunocytochemistry-Immunofluorescence-NBP2-72205-img0002.jpg)